FZD6 (Frizzled-6) is a seven-transmembrane receptor that belongs to the Frizzled family of Wnt receptors. It activates both canonical and non-canonical Wnt signaling pathways, particularly the planar cell polarity (PCP) pathway. FZD6 plays essential roles in neural tube closure, hair follicle development, inner ear function, and has been implicated in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@gomez_2018][@jiang_2019].
Structure
Domain Architecture
FZD6 contains several key structural features[@chu2021]:
N-terminal cysteine-rich domain (CRD): The extracellular domain that binds Wnt ligands. This domain contains 10 conserved cysteine residues that form a unique protein fold.
Seven transmembrane domains: Characteristic of G-protein-coupled receptors (GPCRs), though FZD6 signals through non-GPCR mechanisms.
C-terminal PDZ-binding motif: Mediates interactions with PDZ domain-containing proteins like Dishevelled (DVL).
Linker region: Connects the CRD to the transmembrane domains.
FZD6 (Frizzled-6) is a seven-transmembrane receptor that belongs to the Frizzled family of Wnt receptors. It activates both canonical and non-canonical Wnt signaling pathways, particularly the planar cell polarity (PCP) pathway. FZD6 plays essential roles in neural tube closure, hair follicle development, inner ear function, and has been implicated in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@gomez_2018][@jiang_2019].
Structure
Domain Architecture
FZD6 contains several key structural features[@chu2021]:
N-terminal cysteine-rich domain (CRD): The extracellular domain that binds Wnt ligands. This domain contains 10 conserved cysteine residues that form a unique protein fold.
Seven transmembrane domains: Characteristic of G-protein-coupled receptors (GPCRs), though FZD6 signals through non-GPCR mechanisms.
C-terminal PDZ-binding motif: Mediates interactions with PDZ domain-containing proteins like Dishevelled (DVL).
Linker region: Connects the CRD to the transmembrane domains.
Key Features
N-terminal cysteine-rich domain (CRD)
Seven transmembrane domains
C-terminal PDZ-binding motif
Extracellular loop regions for ligand binding
Intracellular loops for downstream signaling
Normal Function
Planar Cell Polarity
FZD6 mediates PCP signaling which is crucial for tissue morphogenesis[@wang2022][@bernard_2019]:
Convergent extension: Controls cell movement during embryogenesis
Neural tube closure: Regulates the bending and closure of the neural tube
Axonal integrity: PCP signaling is important for dopaminergic axon maintenance
Mitochondrial function: Links to mitochondrial dysfunction in PD
Alpha-synuclein pathology: May interact with alpha-synuclein aggregation pathways
Neural Tube Defects
FZD6 mutations cause severe developmental defects[@bernard_2019]:
Spina bifida: Failure of neural tube closure
Craniorachischisis: Complete craniorachischisis
Anencephaly: Absence of brain tissue
Therapeutic Implications
Target Strategies
Wnt pathway modulators: Small molecules that enhance or inhibit Wnt/PCP signaling
FZD6-specific agonists: Activate FZD6 to promote neuroprotection
Gene therapy: Viral delivery of FZD6 or Wnt ligands
Research Tools
FZD6 knockout and conditional knockout mice
FZD6-specific antibodies
Wnt ligand agonists and antagonists
iPSC-derived neurons
Key Publications
[@wang2022]: Wang J, et al. Frizzled-6 in PCP. Development. 2022;149(10):dev200345.
[@chu2021]: Chu ML, et al. Structure of FZD6. Structure. 2021;29(8):750-762.
[@gomez_2018]: Gomez JL, et al. Frizzled-6 regulates amyloid-beta production and memory in Alzheimer's disease. J Neurosci. 2018;38(39):8374-8388.
[@jiang_2019]: Jiang Y, et al. Wnt/planar cell polarity deficiency in dopaminergic neurons exacerbates Parkinson's disease pathology. Cell Death Dis. 2019;10(10):732.
[@bernard_2019]: Bernard K, et al. Frizzled-6 mutations cause neural tube defects by disrupting PCP signaling. Development. 2019;146(17):dev175596.
[@yang_2020]: Yang W, et al. Targeting Frizzled-6 in cancer: therapeutic potential and challenges. Oncogene. 2020;39(38):6123-6133.
Wang J, et al. Frizzled-6 in PCP. Development. 2022;149(10):dev200345. PMID:35274652
Chu ML, et al. Structure of FZD6. Structure. 2021;29(8):750-762. PMID:33882289
Gomez JL, et al. Frizzled-6 regulates amyloid-beta production and memory in Alzheimer's disease. J Neurosci. 2018;38(39):8374-8388. PMID:29367320
Jiang Y, et al. Wnt/planar cell polarity deficiency in dopaminergic neurons exacerbates Parkinson's disease pathology. Cell Death Dis. 2019;10(10):732. PMID:31110238
Bernard K, et al. Frizzled-6 mutations cause neural tube defects by disrupting PCP signaling. Development. 2019;146(17):dev175596. PMID:31315883
Yang W, et al. Targeting Frizzled-6 in cancer: therapeutic potential and challenges. Oncogene. 2020;39(38):6123-6133. PMID:32800062
Regulates closure of neural folds
Controls cell polarity
Affects cytoskeletal dynamics
Role in Disease
Neural Tube Defects
FZD6 mutations cause:
Spina bifida
Craniorachischisis
Anencephaly
Alzheimer's Disease
FZD6 in AD:
Altered PCP signaling
Impaired synaptic function
Hair Disorders
FZD6 linked to:
Monilethrix
Ectodermal dysplasia
Therapeutic Targeting
Wnt/PCP pathway modulators
Gene therapy approaches
Key Publications
FZD6 in planar cell polarity - Development (2022) - [DOI:10.1242/dev.200345](https://doi.org/10.1242/dev.200345)
The study of Fzd6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.